Julie Hambleton Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Julie Hambleton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Julie Hambleton. Julie Hambleton is a EVP & Chief Medical Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and a SVP & Chief Medical Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and a Director in IGM Biosciences, Inc. ($IGMS) and a SVP, Chief Medical Officer in IDEAYA Biosciences, Inc. ($IDYA) and a Director in SpringWorks Therapeutics, Inc. ($SWTX).
Address: C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO 94080 CA
Companies in which Julie Hambleton is an Insider
FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Julie Hambleton: EVP & Chief Medical Officer, SVP & Chief Medical Officer
Holdings: 84,811 shares
Current Value: $3,848,723
Latest Transaction: Nov 13 2015
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDEAYA Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Julie Hambleton: SVP, Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Feb 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IGM Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Julie Hambleton: Director
Holdings: 3,000 shares
Latest Transaction: Jun 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SpringWorks Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Julie Hambleton: Director
Holdings: 5,995 shares
Latest Transaction: May 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Julie Hambleton
Sentiment: All, FPRX, IDYA, IGMS, SWTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Sell | S | 80.00 | 2,000 | 160,000 | 3,000 | 5 K to 3 K (-40.00 %) |
| Jun 03 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Sell | S | 80.00 | 2,000 | 160,000 | 3,000 | 5 K to 3 K (-40.00 %) |
| May 21 2021 | SWTX | SpringWorks Therap ... | Hambleton Julie | Director | Option Exercise | A | 75.94 | 6,998 | 531,428 | 6,998 | |
| May 21 2021 | SWTX | SpringWorks Therap ... | Hambleton Julie | Director | Grant | A | 0.00 | 1,106 | 0 | 5,995 | 4.9 K to 6 K (+22.62 %) |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 25 2020 | IDYA | IDEAYA Biosciences ... | Hambleton Julie | SVP, Chief Medical ... | Option Exercise | A | 6.92 | 62,500 | 432,500 | 62,500 | |
| Feb 07 2020 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Option Exercise | A | 40.27 | 10,000 | 402,700 | 10,000 |